• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解释不等群组大小的阶段式楔形试验获得的功效的变异。

Explaining the variation in the attained power of a stepped-wedge trial with unequal cluster sizes.

机构信息

School of Population and Public Health, University of British Columbia, 2206 E Mall, Vancouver, BC, V6T 1Z3, Canada.

Centre for Health Evaluation and Outcome Sciences, 588-1081 Burrard Street, St Paul's Hospital, Vancouver, BC, V6Z 1Y6, Canada.

出版信息

BMC Med Res Methodol. 2020 Jun 24;20(1):166. doi: 10.1186/s12874-020-01036-5.

DOI:10.1186/s12874-020-01036-5
PMID:32580698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7315519/
Abstract

BACKGROUND

In a cross-sectional stepped-wedge trial with unequal cluster sizes, attained power in the trial depends on the realized allocation of the clusters. This attained power may differ from the expected power calculated using standard formulae by averaging the attained powers over all allocations the randomization algorithm can generate. We investigated the effect of design factors and allocation characteristics on attained power and developed models to predict attained power based on allocation characteristics.

METHOD

Based on data simulated and analyzed using linear mixed-effects models, we evaluated the distribution of attained powers under different scenarios with varying intraclass correlation coefficient (ICC) of the responses, coefficient of variation (CV) of the cluster sizes, number of cluster-size groups, distributions of group sizes, and number of clusters. We explored the relationship between attained power and two allocation characteristics: the individual-level correlation between treatment status and time period, and the absolute treatment group imbalance. When computational time was excessive due to a scenario having a large number of possible allocations, we developed regression models to predict attained power using the treatment-vs-time period correlation and absolute treatment group imbalance as predictors.

RESULTS

The risk of attained power falling more than 5% below the expected or nominal power decreased as the ICC or number of clusters increased and as the CV decreased. Attained power was strongly affected by the treatment-vs-time period correlation. The absolute treatment group imbalance had much less impact on attained power. The attained power for any allocation was predicted accurately using a logistic regression model with the treatment-vs-time period correlation and the absolute treatment group imbalance as predictors.

CONCLUSION

In a stepped-wedge trial with unequal cluster sizes, the risk that randomization yields an allocation with inadequate attained power depends on the ICC, the CV of the cluster sizes, and number of clusters. To reduce the computational burden of simulating attained power for allocations, the attained power can be predicted via regression modeling. Trial designers can reduce the risk of low attained power by restricting the randomization algorithm to avoid allocations with large treatment-vs-time period correlations.

摘要

背景

在不等群组大小的交叉阶段楔形试验中,试验的实际功效取决于群组的实际分配。该实际功效可能与使用标准公式计算的预期功效不同,可通过对随机分配算法生成的所有分配的实际功效进行平均来实现。我们研究了设计因素和分配特征对实际功效的影响,并根据分配特征开发了预测实际功效的模型。

方法

我们基于线性混合效应模型模拟和分析的数据,评估了在不同情况下实际功效的分布,这些情况的反应内相关系数(ICC)、群组大小的变异系数(CV)、群组大小分组数量、群组大小分布和群组数量各不相同。我们探讨了实际功效与两种分配特征之间的关系:治疗状态与时间段之间的个体水平相关性,以及绝对治疗组不平衡性。当由于一个场景的可能分配数量过多而导致计算时间过长时,我们开发了回归模型,使用治疗与时间段的相关性和绝对治疗组不平衡性作为预测因子来预测实际功效。

结果

随着 ICC 或群组数量的增加以及 CV 的降低,实际功效低于预期或名义功效 5%的风险降低。实际功效受到治疗与时间段相关性的强烈影响。绝对治疗组不平衡性对实际功效的影响较小。使用包含治疗与时间段相关性和绝对治疗组不平衡性作为预测因子的逻辑回归模型可以准确预测任何分配的实际功效。

结论

在不等群组大小的阶段楔形试验中,随机分配产生实际功效不足的分配的风险取决于 ICC、群组大小的 CV 和群组数量。为了降低模拟分配实际功效的计算负担,可以通过回归建模来预测实际功效。试验设计者可以通过限制随机分配算法来避免使用具有较大治疗与时间段相关性的分配,从而降低实际功效低的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5f/7315519/2971933618ba/12874_2020_1036_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5f/7315519/40f284e9fec8/12874_2020_1036_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5f/7315519/a6113109fa65/12874_2020_1036_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5f/7315519/4d2d70b78f90/12874_2020_1036_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5f/7315519/3336e6438843/12874_2020_1036_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5f/7315519/1ebaa2520ef8/12874_2020_1036_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5f/7315519/1203aad476bc/12874_2020_1036_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5f/7315519/27e8de4630e0/12874_2020_1036_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5f/7315519/2971933618ba/12874_2020_1036_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5f/7315519/40f284e9fec8/12874_2020_1036_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5f/7315519/a6113109fa65/12874_2020_1036_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5f/7315519/4d2d70b78f90/12874_2020_1036_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5f/7315519/3336e6438843/12874_2020_1036_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5f/7315519/1ebaa2520ef8/12874_2020_1036_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5f/7315519/1203aad476bc/12874_2020_1036_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5f/7315519/27e8de4630e0/12874_2020_1036_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5f/7315519/2971933618ba/12874_2020_1036_Fig8_HTML.jpg

相似文献

1
Explaining the variation in the attained power of a stepped-wedge trial with unequal cluster sizes.解释不等群组大小的阶段式楔形试验获得的功效的变异。
BMC Med Res Methodol. 2020 Jun 24;20(1):166. doi: 10.1186/s12874-020-01036-5.
2
CRTpowerdist: An R package to calculate attained power and construct the power distribution for cross-sectional stepped-wedge and parallel cluster randomized trials.CRTpowerdist:一个用于计算获得的功效并为横截面阶乘楔形和平行群组随机试验构建功效分布的 R 包。
Comput Methods Programs Biomed. 2021 Sep;208:106255. doi: 10.1016/j.cmpb.2021.106255. Epub 2021 Jun 25.
3
The impact of varying cluster size in cross-sectional stepped-wedge cluster randomised trials.不同聚类大小对横向阶段-推移群组随机试验的影响。
BMC Med Res Methodol. 2019 Jun 14;19(1):123. doi: 10.1186/s12874-019-0760-6.
4
Relative efficiency of unequal cluster sizes in stepped wedge and other trial designs under longitudinal or cross-sectional sampling.纵向或横截面抽样下不等群集大小在阶梯楔形和其他试验设计中的相对效率。
Stat Med. 2018 Dec 30;37(30):4652-4664. doi: 10.1002/sim.7943. Epub 2018 Sep 12.
5
swdpwr: A SAS macro and an R package for power calculations in stepped wedge cluster randomized trials.swdpwr:用于阶梯楔形整群随机试验功效计算的SAS宏和R包。
Comput Methods Programs Biomed. 2022 Jan;213:106522. doi: 10.1016/j.cmpb.2021.106522. Epub 2021 Nov 12.
6
The optimal design of stepped wedge trials with equal allocation to sequences and a comparison to other trial designs.序列均等分配的阶梯楔形试验的优化设计及其与其他试验设计的比较。
Clin Trials. 2017 Dec;14(6):639-647. doi: 10.1177/1740774517723921. Epub 2017 Aug 10.
7
8
An imbalance in cluster sizes does not lead to notable loss of power in cross-sectional, stepped-wedge cluster randomised trials with a continuous outcome.在具有连续结局的横断面、阶梯式整群随机试验中,整群大小的不平衡不会导致显著的效能损失。
Trials. 2017 Mar 7;18(1):109. doi: 10.1186/s13063-017-1832-8.
9
The randomization-induced risk of a trial failing to attain its target power: assessment and mitigation.随机化导致试验未能达到目标效力的风险:评估和缓解。
Trials. 2019 Jun 17;20(1):360. doi: 10.1186/s13063-019-3471-8.
10
Power calculation for cross-sectional stepped wedge cluster randomized trials with variable cluster sizes.具有变群大小的横断 stepped wedge 群随机试验的功效计算。
Biometrics. 2020 Sep;76(3):951-962. doi: 10.1111/biom.13164. Epub 2019 Nov 14.

引用本文的文献

1
Power analysis for concurrent balanced or imbalanced multiple-intervention stepped wedge design: a simulation-based approach.并发平衡或不平衡多干预阶梯楔形设计的功效分析:一种基于模拟的方法。
BMC Med Res Methodol. 2025 Apr 16;25(1):96. doi: 10.1186/s12874-025-02546-w.
2
Maintaining the validity of inference from linear mixed models in stepped-wedge cluster randomized trials under misspecified random-effects structures.在随机效应结构指定不当的阶段式楔形群组随机试验中,维持线性混合模型推论的有效性。
Stat Methods Med Res. 2024 Sep;33(9):1497-1516. doi: 10.1177/09622802241248382. Epub 2024 May 29.
3
Comparing analytical strategies for balancing site-level characteristics in stepped-wedge cluster randomized trials: a simulation study.

本文引用的文献

1
Highly efficient stepped wedge designs for clusters of unequal size.高效的不等大小群组的阶梯式楔形设计。
Biometrics. 2020 Dec;76(4):1167-1176. doi: 10.1111/biom.13218. Epub 2020 Feb 3.
2
Power calculation for cross-sectional stepped wedge cluster randomized trials with variable cluster sizes.具有变群大小的横断 stepped wedge 群随机试验的功效计算。
Biometrics. 2020 Sep;76(3):951-962. doi: 10.1111/biom.13164. Epub 2019 Nov 14.
3
The randomization-induced risk of a trial failing to attain its target power: assessment and mitigation.
比较阶段型群组随机试验中平衡地点特征的分析策略:一项模拟研究。
BMC Med Res Methodol. 2023 Sep 12;23(1):206. doi: 10.1186/s12874-023-02027-y.
4
Implementation of increased physical therapy intensity for improving walking after stroke: Walk 'n watch protocol for a multisite stepped-wedge cluster-randomized controlled trial.增加物理治疗强度以改善中风后行走能力的实施:一项多中心阶梯式楔形群组随机对照试验的 Walk 'n watch 方案。
Int J Stroke. 2023 Jan;18(1):117-122. doi: 10.1177/17474930221129982. Epub 2022 Oct 28.
5
Sample size calculators for planning stepped-wedge cluster randomized trials: a review and comparison.用于规划阶乘簇随机对照试验的样本量计算器:综述与比较。
Int J Epidemiol. 2022 Dec 13;51(6):2000-2013. doi: 10.1093/ije/dyac123.
6
Mind the gap: covariate constrained randomisation can protect against substantial power loss in parallel cluster randomised trials.注意差距:协变量约束随机化可防止平行群组随机试验中出现大量的效能损失。
BMC Med Res Methodol. 2022 Apr 13;22(1):111. doi: 10.1186/s12874-022-01588-8.
7
Ethical and epistemic issues in the design and conduct of pragmatic stepped-wedge cluster randomized clinical trials.实用型阶梯式群组随机临床试验设计与实施中的伦理和认识问题。
Contemp Clin Trials. 2022 Apr;115:106703. doi: 10.1016/j.cct.2022.106703. Epub 2022 Feb 15.
8
Methods for dealing with unequal cluster sizes in cluster randomized trials: A scoping review.处理整群随机试验中不等群组大小的方法:范围综述。
PLoS One. 2021 Jul 29;16(7):e0255389. doi: 10.1371/journal.pone.0255389. eCollection 2021.
9
Improving efficiency in the stepped-wedge trial design via Bayesian modeling with an informative prior for the time effects.通过贝叶斯建模,利用时间效应的信息先验,提高阶式楔形试验设计的效率。
Clin Trials. 2021 Jun;18(3):295-302. doi: 10.1177/1740774520980052. Epub 2021 Apr 5.
随机化导致试验未能达到目标效力的风险:评估和缓解。
Trials. 2019 Jun 17;20(1):360. doi: 10.1186/s13063-019-3471-8.
4
The impact of varying cluster size in cross-sectional stepped-wedge cluster randomised trials.不同聚类大小对横向阶段-推移群组随机试验的影响。
BMC Med Res Methodol. 2019 Jun 14;19(1):123. doi: 10.1186/s12874-019-0760-6.
5
Sample size calculation for stepped-wedge cluster-randomized trials with more than two levels of clustering.两水平以上整群随机试验的样本量计算。
Clin Trials. 2019 Jun;16(3):225-236. doi: 10.1177/1740774519829053. Epub 2019 Apr 24.
6
Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration.报告阶梯式楔形群随机试验:CONSORT 2010 声明的扩展,附有解释和说明。
BMJ. 2018 Nov 9;363:k1614. doi: 10.1136/bmj.k1614.
7
A study of target effect sizes in randomised controlled trials published in the Health Technology Assessment journal.一项对发表在《卫生技术评估》杂志上的随机对照试验中目标效应大小的研究。
Trials. 2018 Oct 10;19(1):544. doi: 10.1186/s13063-018-2886-y.
8
Relative efficiency of unequal cluster sizes in stepped wedge and other trial designs under longitudinal or cross-sectional sampling.纵向或横截面抽样下不等群集大小在阶梯楔形和其他试验设计中的相对效率。
Stat Med. 2018 Dec 30;37(30):4652-4664. doi: 10.1002/sim.7943. Epub 2018 Sep 12.
9
Information content of cluster-period cells in stepped wedge trials.阶梯楔形试验中聚类周期细胞的信息含量
Biometrics. 2019 Mar;75(1):144-152. doi: 10.1111/biom.12959. Epub 2018 Aug 23.
10
Stepped wedge designs: insights from a design of experiments perspective.阶梯楔形设计:从实验设计角度的见解
Stat Med. 2017 Oct 30;36(24):3772-3790. doi: 10.1002/sim.7403. Epub 2017 Aug 8.